Immunotherapy Combos on Horizon for Ovarian Cancer – OncLive
OncLive |
Immunotherapy Combos on Horizon for Ovarian Cancer
OncLive Several phase III studies are exploring immunotherapy combinations for patients with ovarian cancer, with the potential to disrupt the systemic treatment paradigm for these patients, according to Camille Gunderson, MD, who spoke at the SGO 2018 Annual … |
